319
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Health risks of consuming apples with carbendazim, imidacloprid, and thiophanate-methyl in the Chinese population: Risk assessment based on a nonparametric probabilistic evaluation model

, , , , , & show all
Pages 1106-1121 | Received 20 Nov 2015, Accepted 30 Dec 2015, Published online: 31 Mar 2016
 

ABSTRACT

The pesticides carbendazim (CA), imidacloprid (IM), and thiophanate-methyl (TH) are used extensively in apple production. However, the presence of pesticide residues in apples has been associated with a wide range of human health hazards. To assess whether apples are safe to consume, evaluating their potential health risk is of great significance. We tested apples from two dominant apple-producing areas for the presence of pesticide residues and constructed a statistical model to evaluate their health risks. Of the three commonly used pesticides, thirty-two samples (11.3% of all tested samples) were residue-free and 231 (81.9%) contained CA residues, which was the most frequently detectable pesticide, followed by TH (52.1%) and IM (39.0%). All of the samples were below the maximum residue limits. The probabilistic assessment results indicated that the pesticide intake risks for kids (aged 2–6 years) and children (aged 7–13 years) were significantly higher than those of other groups, so that they were the vital monitoring objects. Our findings indicate that consumption of apples with these three pesticides does not pose a health threat for the population. Nevertheless, we recommend an investigation into continuous monitoring and stricter regulations on fruits' quality and safety throughout China.

Funding

This work was supported by the National Program for Quality and Safety Risk Assessment of Agricultural Products of China (No. GJFP2014002 and GJFP2015002), the Core Research Budget of the Non-profit Governmental Research Institution (No. 0032014013), and the Chinese Academy of Agricultural Science and Technology Innovation Projects (No. CAAS-ASTIP).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.